Holen Sie sich die Stockscreener-App
71.65
1.26%
0.89
Schlusskurs vom Vortag:
$70.76
Offen:
$70.7
24-Stunden-Volumen:
7.89M
Relative Volume:
4.48
Marktkapitalisierung:
$16.26B
Einnahmen:
$4.03B
Nettoeinkommen (Verlust:
$789.50M
KGV:
37.12
EPS:
1.93
Netto-Cashflow:
$1.15B
1W Leistung:
-2.72%
1M Leistung:
-8.19%
6M Leistung:
-0.78%
1J Leistung:
+1.89%
1-Tages-Spanne:
$70.36
$71.95
1-Wochen-Bereich:
$70.36
$74.02
52-Wochen-Spanne:
$70.36
$84.67
Hologic Inc Stock (HOLX) Company Profile
Firmenname
Hologic Inc
Sektor
Telefon
(508) 263-2900
Adresse
250 CAMPUS DRIVE, MARLBOROUGH, MA
Vergleichen Sie HOLX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HOLX
Hologic Inc
|
71.65 | 16.26B | 4.03B | 789.50M | 1.15B | 3.33 |
|
ISRG
Intuitive Surgical Inc
|
524.43 | 186.79B | 7.87B | 2.24B | 586.00M | 6.22 |
|
BDX
Becton Dickinson Co
|
227.68 | 65.83B | 20.18B | 1.71B | 3.07B | 5.94 |
|
ALC
Alcon Inc
|
84.76 | 41.92B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
237.27 | 34.83B | 4.81B | 1.11B | 1.35B | 7.55 |
|
WST
West Pharmaceutical Services Inc
|
331.40 | 24.00B | 2.88B | 499.60M | 321.60M | 6.74 |
Hologic Inc Stock (HOLX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-12-10 | Eingeleitet | Jefferies | Hold |
| 2024-12-10 | Bestätigt | Needham | Buy |
| 2024-10-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-06-27 | Eingeleitet | Stephens | Overweight |
| 2024-04-03 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-07-14 | Hochstufung | Needham | Hold → Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2022-07-20 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-07-20 | Eingeleitet | UBS | Neutral |
| 2022-07-18 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-04-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2021-12-15 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-10-14 | Eingeleitet | Redburn | Neutral |
| 2021-07-06 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2020-11-20 | Herabstufung | Needham | Buy → Hold |
| 2020-11-05 | Bestätigt | Needham | Buy |
| 2020-06-30 | Hochstufung | Cowen | Market Perform → Outperform |
| 2020-06-03 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-04-30 | Bestätigt | Needham | Buy |
| 2020-04-30 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2020-04-07 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2020-03-27 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2020-01-13 | Bestätigt | Needham | Buy |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2020-01-02 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-09-26 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-08-01 | Bestätigt | Needham | Buy |
| 2019-05-02 | Bestätigt | Needham | Buy |
| 2019-01-31 | Bestätigt | Needham | Buy |
| 2019-01-02 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2018-10-09 | Eingeleitet | UBS | Neutral |
| 2018-09-13 | Herabstufung | BofA/Merrill | Buy → Neutral |
Alle ansehen
Hologic Inc Aktie (HOLX) Neueste Nachrichten
Hologic stock touches 52-week low at $70.5 amid market shifts - Investing.com
Hologic (NASDAQ:HOLX) Hits New 52-Week LowTime to Sell? - MarketBeat
Hologic stock touches 52-week low at $70.5 amid market shifts By Investing.com - Investing.com South Africa
Hologic, Inc. (NASDAQ:HOLX) Shares Acquired by Franklin Resources Inc. - MarketBeat
Here's Why Hologic (HOLX) Fell More Than Broader Market - Yahoo Finance
Problems With Recalled BioZorb Markers Could Cause Severe Injury or Death, FDA Warns - AboutLawsuits.com
Needham & Company LLC Reiterates "Buy" Rating for Hologic (NASDAQ:HOLX) - MarketBeat
Hologic agrees with CDC to develop reagents for H5N1 bird flu testing - Yahoo Finance
Hologic recalls BioZorb Marker over safety concerns - MSN
Hologic's SWOT analysis: women's health tech firm faces growth challenges By Investing.com - Investing.com South Africa
Hologic's SWOT analysis: women's health tech firm faces growth challenges - Investing.com India
Hologic recalls BioZorb Marker over safety concerns (HOLX:NASDAQ) - Seeking Alpha
Hologic Inc. stock outperforms competitors despite losses on the day - MarketWatch
Hologic Inks Deal with CDC for H5N1 Bird Flu Test Development - MPO-mag
Peering Into Hologic's Recent Short Interest - Benzinga
Hologic to Contribute to H5N1 Bird Flu Test Development via Agreement Issued by CDCHologic, Inc. - Hologic, Inc. - Investor Relations
Hologic Partners with CDC to Combat Bird Flu Crisis: Develops H5N1 Detection System - StockTitan
Danbury corporate building sold for $7 million to firm founded by combat hero and Navy commander - Greenwich Time
Digital Breast Tomosynthesis Equipment Market Is Booming - openPR
Hologic Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Body Fat Measurement Devices Market Forecasted CAGR 6.3%, - openPR
Breast Cancer Core Needle Biopsy Market Top PlayersIntact - openPR
Hologic (NASDAQ:HOLX) Research Coverage Started at Wolfe Research - Defense World
FY2025 EPS Estimates for Hologic Raised by Leerink Partnrs - MarketBeat
13,629 Shares in Hologic, Inc. (NASDAQ:HOLX) Acquired by Oddo BHF Asset Management Sas - MarketBeat
Hologic, Inc. (NASDAQ:HOLX) Sees Significant Increase in Short Interest - MarketBeat
Hologic, Inc. (NASDAQ:HOLX) Shares Acquired by Toronto Dominion Bank - MarketBeat
Hologic initiated with a Peer Perform at Wolfe amid near-term headwinds - Yahoo Finance
Wolfe Research Initiates Coverage of Hologic (HOLX) with Peer Perform Recommendation - MSN
Hologic, Inc. (NASDAQ:HOLX) Shares Sold by Retirement Systems of Alabama - MarketBeat
Hologic (HOLX) Stock Moves -1.93%: What You Should Know - Yahoo Finance
Hologic Inc. stock underperforms Friday when compared to competitors - MarketWatch
Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It - MSN
Hologic (NASDAQ:HOLX) Now Covered by Wolfe Research - MarketBeat
BioZorb Lawuit LawyerBreast Biopsy Marker RecallDecember 2024 Update - Levin Papantonio
XTX Topco Ltd Takes Position in Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Geode Capital Management LLC Purchases 13,812 Shares of Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Barclays PLC Acquires 231,578 Shares of Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Public Employees Retirement System of Ohio Has $9.58 Million Stock Position in Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Hologic Beats on Both Top and Bottom Lines - AOL
Hologic Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Hologic's SWOT analysis: diagnostics firm faces growth challenges - Investing.com
Hologic (NASDAQ:HOLX) Upgraded to Strong-Buy at BNP Paribas - MarketBeat
Nomura Asset Management Co. Ltd. Grows Position in Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Hologic Trades at 17.62X P/E: Should You Buy, Sell or Hold the Stock? - Yahoo Finance
24,363 Shares in Hologic, Inc. (NASDAQ:HOLX) Acquired by Y Intercept Hong Kong Ltd - MarketBeat
Aesthetic Medicine Market Opportunities and Key Growth - openPR
Hologic, Inc. (NASDAQ:HOLX) Shares Sold by Wellington Management Group LLP - MarketBeat
Hologic, Inc. (NASDAQ:HOLX) Shares Purchased by National Bank of Canada FI - MarketBeat
EP Wealth Advisors LLC Buys Shares of 9,956 Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Why Is Hologic Inc. (HOLX) Among the Best Cosmetic Surgery and Aesthetics Stocks to Invest In Now? - MSN
Finanzdaten der Hologic Inc-Aktie (HOLX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.18%
2.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):